CVS Health Corporation is the largest pharmacy health care provider in the U.S. With its new focus on health and wellness, CVS in early September 2014 announced that it would no longer sell cigarettes and other tobacco products at all its pharmacy outlets. CVS is trading below my calculated fair value and has demonstrated an exceptional ability to grow its dividend at a high rate, averaging nearly 25% per year since 2005.
CVS enjoys a strong market share in the relatively stable U.S. retail drug industry. The company in July 2014 launched a generic drug joint venture with Cardinal Health (NYSE:CAH). This should result in decreasing drug purchasing costs as contracts are renewed throughout 2015. CVS earned one Star in the Fair Value section, earned two Stars in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of four Stars. This quantitatively ranks CVS as...
Source: Seeking Alpha
Related Articles:
- Lockheed Martin Corp. Priced To Buy
- Dividend Stock Analysis: McDonald's Corporation, One To Watch Closely
- Dividend Stock Analysis: Is It Time To Buy ConocoPhillips?
- Dividend Stock Analysis: Leggett & Platt, A Solid Steady Performer
- More Stock Analysis
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.